Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Completed · Phase 2

Conditions studied: Opioid-Related Disorders, Substance-Related Disorders

In brief

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Key facts

Study ID

NCT00000318

Run by

National Institute on Drug Abuse (NIDA)

People needed

202

Starts

1994-12-01

Expected to finish

2007-08-01

Last updated by the study team

2017-01-12

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• APT Residential Services Division — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.